GLP-1 Stocks Aren't the Only Way to Benefit From the Weight Loss Drugs Boom

By Yahoo! Finance | Oct 13, 2024 at 09:40 AM EST

Weight loss drugs targeting GLP-1 receptors like Zepbound and Wegovy are popular, but other companies offer innovative alternatives. Zealand Pharma's petrelintide activates amylin and calcitonin receptors, potentially providing better outcomes than GLP-1 drugs.

Did you find this insightful?

Bad

Just Okay

Amazing

We are preparing, please wait

New Alert

Select an alert type

Sentiment Spike

Send email alert if news sentiment changes significantly

Mentions Spike

Send email alert if has a surge in mentions

Choose sentiment spike or mentions spike or both to receive email alerts and app notification for the selected stock.
Note: Please be aware that you will receive an email only once a day, around 8:00 AM (EST), in the event of any spike.
In future if you don't want to receive any email then delete stocks added into alert section.